Real-time enrollment status for this nodular basal cell carcinoma clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 8:20 PM UTC
| NCT Number | NCT07670858 |
| Recruiting Status | Recruiting |
| Condition | Nodular Basal Cell Carcinoma |
| Phase | PHASE1 |
| Target Enrollment | 48 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Feldan Therapeutics |
| Last Updated on CT.gov | June 29, 2026 (2 weeks ago) |
As of July 19, 2026: Clinical trial NCT07670858 is currently recruiting participants. This phase1 study for nodular basal cell carcinoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Feldan Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07670858 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07670858 was last updated 2 weeks ago (June 29, 2026). HelloStudys verifies this status automatically.